Recent News

• 01.22.2025 - Hepion Pharmaceuticals Announces $9.0 Million Public Offering
• 12.11.2024 - Hepion Pharmaceuticals, Inc. Announces Termination of Merger Agreement with Pharma Two B Ltd.
• 12.05.2024 - Pharma Two B Announces Poster Presentation on P2B001 at the Annual Meeting of the Parkinson’s Disease Study Group

Recent Filings

• 02.07.2025 - ARS Annual Report to Security Holders
• 02.07.2025 - DEF 14A Other definitive proxy statements
• 01.27.2025 - PRE 14A Other preliminary proxy statements
• 01.27.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 01.23.2025 - 424B4 Prospectus [Rule 424(b)(4)]
• 01.21.2025 - S-1MEF Registration adding securities to prior Form S-1 registration [Rule 462(b)]
• 01.21.2025 - EFFECT Notice of Effectiveness
• 01.15.2025 - 8-K Current report
• 01.14.2025 - S-1/A General form for registration of securities under the Securities Act of 1933
• 01.13.2025 - 10-K/A Annual report [Section 13 and 15(d), not S-K Item 405]